Literature DB >> 25270372

Spatial distribution of malignant tissue in gliomas: correlations of 11C-L-methionine positron emission tomography and perfusion- and diffusion-weighted magnetic resonance imaging.

Anna Tietze1, Jens K Boldsen2, Kim Mouridsen2, Lars Ribe2, Suzan Dyve3, Søren Cortnum4, Leif Østergaard5, Per Borghammer6.   

Abstract

BACKGROUND: The prognosis of glioma patients is contingent on precise target selection for stereotactic biopsies and the extent of tumor resection. (11)C-L-methionine (MET) positron emission tomography (PET) demonstrates tumor heterogeneity and invasion with high diagnostic accuracy.
PURPOSE: To compare the spatial tumor distribution delineated by MET PET with that by perfusion- and diffusion-weighted magnetic resonance imaging (MRI), in order to understand the diagnostic value of these MRI methods, when PET is not available.
MATERIAL AND METHODS: Presurgical MET PET and MRI, including perfusion- and diffusion-weighted MRI, were acquired in 13 patients (7 high-grade gliomas, 6 low-grade gliomas). A quantitative volume of interest analysis was performed to compare the modalities objectively, supplemented by a qualitative evaluation that assessed the clinical applicability.
RESULTS: The inaccuracy of conventional MRI was confirmed (area under the curve for predicting voxels with high MET uptake = 0.657), whereas cerebral blood volume (CBV) maps calculated from perfusion data improved accuracy (area under the curve = 0.760). We considered CBV maps diagnostically comparable to MET PET in 5/7 cases of high-grade gliomas, but insufficient in all cases of low-grade gliomas when evaluated subjectively. Cerebral blood flow and apparent diffusion coefficient maps did not contribute to further accuracy.
CONCLUSION: Adding perfusion-weighted MRI to the presurgical protocol can increase the diagnostic accuracy of conventional MRI and is a simple and well-established method compared to MET PET. However, the definition of low-grade gliomas with subtle or no alterations on cerebral blood volume maps remains a diagnostic challenge for stand-alone MRI. © The Foundation Acta Radiologica 2014.

Entities:  

Keywords:  CNS; PET; brain/brain stem; comparative study; perfusion- and diffusion-weighted magnetic resonance imaging; primary neoplasms

Mesh:

Substances:

Year:  2014        PMID: 25270372     DOI: 10.1177/0284185114550020

Source DB:  PubMed          Journal:  Acta Radiol        ISSN: 0284-1851            Impact factor:   1.990


  12 in total

Review 1.  Positron emission tomography of high-grade gliomas.

Authors:  Guido Frosina
Journal:  J Neurooncol       Date:  2016-02-20       Impact factor: 4.130

Review 2.  Discrimination between primary low-grade and high-grade glioma with 11C-methionine PET: a bivariate diagnostic test accuracy meta-analysis.

Authors:  Anna Falk Delgado; Alberto Falk Delgado
Journal:  Br J Radiol       Date:  2018-01-22       Impact factor: 3.039

3.  Volumetric assessment of recurrent or progressive gliomas: comparison between F-DOPA PET and perfusion-weighted MRI.

Authors:  Francesco Cicone; Christian P Filss; Giuseppe Minniti; Camilla Rossi-Espagnet; Annalisa Papa; Claudia Scaringi; Norbert Galldiks; Alessandro Bozzao; N Jon Shah; Francesco Scopinaro; Karl-Josef Langen
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-03-07       Impact factor: 9.236

4.  Glioma grading by dynamic susceptibility contrast perfusion and 11C-methionine positron emission tomography using different regions of interest.

Authors:  Cornelia Brendle; Johann-Martin Hempel; Jens Schittenhelm; Marco Skardelly; Gerald Reischl; Benjamin Bender; Ulrike Ernemann; Christian la Fougère; Uwe Klose
Journal:  Neuroradiology       Date:  2018-02-20       Impact factor: 2.804

5.  Whole-tumor histogram analysis of the cerebral blood volume map: tumor volume defined by 11C-methionine positron emission tomography image improves the diagnostic accuracy of cerebral glioma grading.

Authors:  Rongli Wu; Yoshiyuki Watanabe; Atsuko Arisawa; Hiroto Takahashi; Hisashi Tanaka; Yasunori Fujimoto; Tadashi Watabe; Kayako Isohashi; Jun Hatazawa; Noriyuki Tomiyama
Journal:  Jpn J Radiol       Date:  2017-09-06       Impact factor: 2.374

6.  Combining 18F-DOPA PET and MRI with perfusion-weighted imaging improves delineation of high-grade subregions in enhancing and non-enhancing gliomas prior treatment: a biopsy-controlled study.

Authors:  Antoine Girard; Pierre-Jean Le Reste; Alice Metais; Beatrice Carsin Nicol; Dan Cristian Chiforeanu; Elise Bannier; Boris Campillo-Gimenez; Anne Devillers; Xavier Palard-Novello; Florence Le Jeune
Journal:  J Neurooncol       Date:  2021-10-22       Impact factor: 4.130

7.  Simultaneous evaluation of brain tumour metabolism, structure and blood volume using [(18)F]-fluoroethyltyrosine (FET) PET/MRI: feasibility, agreement and initial experience.

Authors:  Otto M Henriksen; Vibeke A Larsen; Aida Muhic; Adam E Hansen; Henrik B W Larsson; Hans S Poulsen; Ian Law
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-12       Impact factor: 9.236

Review 8.  Clinical PET/MRI in neurooncology: opportunities and challenges from a single-institution perspective.

Authors:  Lisbeth Marner; Otto M Henriksen; Michael Lundemann; Vibeke Andrée Larsen; Ian Law
Journal:  Clin Transl Imaging       Date:  2016-11-18

Review 9.  Amino acid PET and MR perfusion imaging in brain tumours.

Authors:  Christian P Filss; Francesco Cicone; Nadim Jon Shah; Norbert Galldiks; Karl-Josef Langen
Journal:  Clin Transl Imaging       Date:  2017-03-13

Review 10.  Combined Amino Acid Positron Emission Tomography and Advanced Magnetic Resonance Imaging in Glioma Patients.

Authors:  Philipp Lohmann; Jan-Michael Werner; N Jon Shah; Gereon R Fink; Karl-Josef Langen; Norbert Galldiks
Journal:  Cancers (Basel)       Date:  2019-01-29       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.